Medicus Pharma (MDCX) Retained Earnings (2023 - 2026)

Medicus Pharma's (MDCX) quarterly Retained Earnings came in at $10880.0 in Q4 2025, up 217700.0% on a QoQ basis from -$5.0 in Q3 2025.

Medicus Pharma (MDCX) Retained Earnings (2023 - 2026) Analysis & Trends

Medicus Pharma (MDCX) has 2 years of Retained Earnings data on file, last reported at $10880.0 in Q4 2025.

Quarterly Retained Earnings changed N/A year-over-year to $10880.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10880.0 (changed N/A YoY) and the FY2025 annual result came in at $10880.0, changed N/A from the prior year.
Retained Earnings grew to $10880.0 in Q4 2025, from -$5.0 in the prior quarter.
In the past five years, Retained Earnings ranged from a high of $5.6 million in Q2 2025 to a low of -$17.7 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Retained Earnings (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	171.67 Bn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	-17.33 Bn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	63.27 Bn
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	12.59 Bn
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	-22.28 Bn
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	9.53 Bn
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	112.09 Bn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	15.38 Bn
10	Medicus Pharma	14.88 Mn	-298,205.43	-	-85.01 Mn

Download Data